Skip to content

Accedeo Group Initiates Rapid Fundraising Campaign, Aiming to Gather as Much as €230 Million

New shares worth 7.5 million Swiss Francs (CHF 0.10 each) are being rapidly sold by our organization, drawing from our existing authorized capital.

Accedo Group initiates an expedited stock sale, aiming to gather up to 230 million Euros
Accedo Group initiates an expedited stock sale, aiming to gather up to 230 million Euros

Accedeo Group Initiates Rapid Fundraising Campaign, Aiming to Gather as Much as €230 Million

ASP Isotopes Inc., a global talent advisory and solutions company headquartered in Zurich, Switzerland, has announced a private placement of up to 7,500,000 new shares. The offering is aimed at raising approximately $60 million in gross proceeds to fund general corporate purposes, including working capital and capital expenditures.

The private placement is structured as a registered direct offering under an effective SEC registration statement and is managed jointly by Cantor and Canaccord Genuity. The sale of the shares will be made to a single institutional investor at a price of $8.00 per share. The closing of the offering is expected around July 25, 2025, subject to usual conditions.

A significant portion of the net proceeds from the Capital Increase will be used to fund the acquisition of AKKA Technologies, though the exact details regarding the acquisition are yet to be disclosed.

The new shares carry full dividend rights for the fiscal year 2021 beginning on 1 January 2021, and the first day of trading for the new shares is expected to be 9 September 2021. Each new share has a par value of CHF 0.10.

The offering is directed only at professional investors, falling under specific regulations, and is not intended for the general public. No reliance may be placed by any person for any purpose on the information contained in this announcement or its accuracy, fairness, or completeness.

The securities referred to in this announcement have not been and will not be registered under the US Securities Act of 1933, as amended, and may not be offered or sold in the United States unless the securities are registered under the Securities Act, or an exemption from the registration requirements of the Securities Act is available.

The Company has agreed to a lock-up period of 90 days from the Settlement Date, subject to customary exceptions. The placement price of the new shares will be determined in the accelerated bookbuilding process and is expected to be published tomorrow morning prior to market opening.

It is important to note that this announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements are subject to risks and uncertainties, and their actual results may differ materially from those expressed or implied in such statements.

This announcement does not constitute an offer or invitation to subscribe for or purchase any securities to any person in Switzerland, the United States, Australia, Canada, Japan, or any jurisdiction to whom or in which such offer or solicitation is unlawful.

[1] Information subject to change without notice.

In light of ASP Isotopes Inc.'s private placement, the future of work might see substantial investments in finance, as a large portion of the net proceeds will be allocated towards the acquisition of AKKA Technologies. This acquisition, though details are yet to be disclosed, could significantly influence the company's financial structure and operations.

Read also:

    Latest